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Legal 'highs' available through the internet-implications and solutions?
Abstract
Prescription drugs are purchased via the Internet, but the consistent finding across many different
populations is that the Internet appears to be a relatively minor source for illicit purchases of prescription
medications by individual end users, the obvious exception being phosphodiesterase inhibitors for
erectile dysfunction. In contrast, the world of escalating availability of illicit drugs via the Internet is
paralleled by escalating availability of ‘legal highs’ via the Internet. These sites represent an important
public health challenge, not least because of the ease of purchase but also because of the ‘relative
anonymity’ for the purchaser.
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Commentary
Legal ‘highs’ available through the Internet–implications
and solutions?
A.L. JONES
From the School of Medicine, University of Western Sydney, Sydney, New South Wales, Australia

Prescription drugs are purchased via the Internet,
but the consistent finding across many different
populations is that the Internet appears to be a relatively minor source for illicit purchases of prescription medications by individual end users,1 the
obvious exception being phosphodiesterase inhibitors for erectile dysfunction.2 In contrast, the world
of escalating availability of illicit drugs via the
Internet3–5 is paralleled by escalating availability of
‘legal highs’ via the Internet.6 These sites represent
an important public health challenge, not least because of the ease of purchase but also because of
the ‘relative anonymity’ for the purchaser.4
Dennehy et al.6 evaluated 28 Internet sites selling
119 ‘legal highs’. Most sites were hosted in the USA
(54%), and 47% of the products were deliberately
likened to illicit drugs, such as cannabis (48%)
or MDMA (3,4-methylenedioxymetamphetamine,
Ecstasy; 23%). The ‘most common ingredients of
these products were ephedra alkaloids (27%),
Salvia divinorum (17%), kava (10%), guarana
(10%), Acorus calamus (10%) and damiana
(10%)’.6 Clearly, this provides evidence that herbal
drugs are being marketed for use as legal alternatives to illicit drugs of abuse, and as health care
professionals we certainly need to be aware of this.
Of course, what is marketed for purchase through
the Internet may not be reflected in the product actually supplied. For example, analysis of the contents of counterfeit phosphodiesterase inhibitors
‘Viagra rips offs’ shows inconsistent doses of active
ingredients (from 0% to >200% of stated dose) and

contaminants including talcum powder, commercial
paint and printer ink.2 In one analysis, only 10% of
samples were within 10% of the stated tablet
strength.2 Of men who purchase prescription-only
medication for erectile dysfunction without a prescription, 67% do so using the Internet.2
Counterfeit phosphodiesterase inhibitors pose
direct and indirect risks to health, including circumvention of proper medical assessment prior to use.2
In this edition of the Q J Med, the paper by Wood
et al. examines the biochemical composition of a
range of ‘legal highs’ readily available to the UK
via the Internet, and shows that the quantity of
active ingredient varies considerably from batch to
batch and thus—caveat emptor—may not be what is
advertised.7 This research is important because it
shows the inconsistency of product between batches
and the potential for unwanted toxicity as a result
from ‘legal highs’.
Following the accidental death of two teenagers
taking legal mephedrone in the UK and the subsequent debate about its re-classification as Class B
prohibited drug (http://www.dailymail.co.uk/news/
article-1258384/Schools-mephedrone-Meow-Meow
-ban-teenage-deaths.html), the Internet availability
of illicit and legal highs takes on an imperative for
further investigation. How much further can expansion of sales over the Internet reasonably be expected to increase? How can governments regulate
such sales?8 How can the ‘quality’ of such products
be regulated?8 Liang states that ‘virtually no accountability exists to ensure safety . . . . Importantly,
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are needed to limit the potential scope of this
problem.5
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search engines . . . although purportedly requiring
‘‘verification’’ of Internet drug sellers using
PharmacyChecker.com
requirements,
actually
allow and profit from illicit drug sales from unverified websites. These search engines are not held accountable for facilitating illegal activities.’ Liang
suggests that in the USA the solution is to create a
‘no-cost/low-cost national Drug Access Program to
break the chain of demand from vulnerable patient
populations and illicit online sellers, makes all
Internet drug sales illegal unless the Internet pharmacy is licensed through a national Internet pharmacy licensing program, prohibits financial
transactions for illegal online drug sales, and establishes criminal penalties for all parties—including
websites, search engines and health care providers—who engage in and facilitate this harmful
activity’.
Another suggested approach is to ‘reduce abuse
potential through the use of abuse-resistant drug designs’.9 Such drugs were found to have significantly
lower levels of abuse than comparator drugs without
such designs.
The escalation of illicit and ‘legal high’ drug availability via the Internet requires new law enforcement and public health initiatives to minimize
harm. At the very least, continued monitoring of
what is offered and sold from such sites will be
needed to determine whether efforts to reduce the
availability of drugs are successful, and what exactly
is being supplied to the public. Education of
consumers and physicians as well as further
International concerted governmental interventions

